CELZ vs LEN · rev $11.0K vs rev $34.19B
Creative Medical Technology Holdings Inc (CELZ) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Creative Medical Technology Holdings Inc (CELZ) is a biotechnology company listed on NASDAQ.
LEN (LEN) common stock.
Latest reported CELZ revenue for 2024-12-31 was $11.0K. Net income was -$5.5M. Revenue was up 22.2% from 2023-12-31 to 2024-12-31. CELZ currently screens at market cap $8.3M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CELZ currently screens at market cap $8.3M. LEN currently screens at market cap $0.
Not investment advice. Open the CELZ and LEN stock pages for the full models.
Not investment advice.